Rare diseases
Investigational molecules
Locations
Back to Czechia207 clinical trials in Novy Hradec Kralove, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
CzechiaStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
CzechiaStudy on Long-Term Effects and Safety of Herpes Zoster Vaccine with Recombinant Varicella Zoster Virus Glycoprotein E in Older Adults
CzechiaStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
CzechiaStudy Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
CzechiaStudy on the Safety and Effectiveness of AZD8630 for Adults with Uncontrolled Asthma at Risk of Exacerbations
CzechiaStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
CzechiaStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
CzechiaStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
CzechiaStudy of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma or Primary Mediastinal Large B-cell Lymphoma
CzechiaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
CzechiaStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on multiple sclerosis and Alzheimer's disease, evaluating novel therapeutic approaches including comparative studies of treatments like frexalimab and investigations of cognitive performance in early-stage Alzheimer's patients with inflammation markers.
Studies aim to assess treatment efficacy and disease progression markers.
Comprehensive research into blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and various lymphomas, testing innovative combination therapies and treatment approaches.
Focus on improving survival rates and treatment outcomes for blood cancer patients.
Studies examining treatments for chronic rhinosinusitis and uncontrolled asthma, with trials evaluating new medications like brensocatib and AZD8630 for symptom management and disease control.
Research focused on improving quality of life for patients with chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
